Pfizer buying Anacor Pharmaceuticals in $5.2B deal
NEW YORK (AP) — Pfizer is buying Anacor Pharmaceuticals Inc. in a deal valued at about $5.2 billion.
NEW YORK (AP) — Pfizer is buying Anacor Pharmaceuticals Inc. in a deal valued at about $5.2 billion.